PCSK9 and hepatocellular carcinoma: In 2024, using HepG2 cells for subcutaneous transplantation and luci‐Hepa1‐6 cells for orthotopic liver injection, the study found that high PCSK9 expression was negatively correlated with overall survival and CD8+ T cell markers in HCC patients.